Literature DB >> 7590103

Molecular actions of ebselen--an antiinflammatory antioxidant.

T Schewe1.   

Abstract

1. Ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one) is a non-toxic seleno-organic drug with antiinflammatory, antiatherosclerotic and cytoprotective properties. 2. Ebselen and some of its metabolites are effective reductants of hydroperoxides including those arising in biomembranes and lipoproteins. 3. By reactions with hydroperoxides and thiols several interconversion cycles are formed which include ebselen metabolites with varying oxidation number of the selenium. 4. In the presence of thiols ebselen mimics the catalytic activities of phospholipid hydroperoxide glutathione peroxidase. 5. Ebselen inhibits at low concentrations a number of enzymes involved in inflammation such as lipoxygenases, NO synthases, NADPH, oxidase, protein kinase C and H+/K(+)-ATPase. The inhibitions are manifested on the cellular level and may contribute to the antiinflammatory potential of ebselen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590103     DOI: 10.1016/0306-3623(95)00003-j

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  72 in total

1.  Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits.

Authors:  Susan M E Smith; Jaeki Min; Thota Ganesh; Becky Diebold; Tsukasa Kawahara; Yerun Zhu; James McCoy; Aiming Sun; James P Snyder; Haian Fu; Yuhong Du; Iestyn Lewis; J David Lambeth
Journal:  Chem Biol       Date:  2012-06-22

2.  Evaluation of the neurotoxic/neuroprotective role of organoselenides using differentiated human neuroblastoma SH-SY5Y cell line challenged with 6-hydroxydopamine.

Authors:  Fernanda Martins Lopes; Giovana Ferreira Londero; Liana Marengo de Medeiros; Leonardo Lisbôa da Motta; Guilherme Antônio Behr; Valeska Aguiar de Oliveira; Mohammad Ibrahim; José Cláudio Fonseca Moreira; Lisiane de Oliveira Porciúncula; João Batista Teixeira da Rocha; Fábio Klamt
Journal:  Neurotox Res       Date:  2012-01-20       Impact factor: 3.911

3.  Toward pyridine-fused selenium-containing antioxidants.

Authors:  Tahli Fenner; Carl H Schiesser
Journal:  Molecules       Date:  2004-05-31       Impact factor: 4.411

4.  High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.

Authors:  Matthew J Saunders; Steven W Graves; Larry A Sklar; Tudor I Oprea; Bruce S Edwards
Journal:  Assay Drug Dev Technol       Date:  2010-02       Impact factor: 1.738

Review 5.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

6.  Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila.

Authors:  Dario C Angeles; Patrick Ho; Ling Ling Chua; Cheng Wang; Yan Wann Yap; Cheehoe Ng; Zhi dong Zhou; Kah-Leong Lim; Zbigniew K Wszolek; Hong Y Wang; Eng King Tan
Journal:  Hum Mol Genet       Date:  2014-01-23       Impact factor: 6.150

7.  Comparative studies on dicholesteroyl diselenide and diphenyl diselenide as antioxidant agents and their effect on the activities of Na+/K+ ATPase and delta-aminolevulinic acid dehydratase in the rat brain.

Authors:  Ige J Kade; Marcio W Paixão; Oscar E D Rodrigues; Nilda B V Barbosa; Antonio L Braga; Daiana S Avila; Cristina W Nogueira; João B T Rocha
Journal:  Neurochem Res       Date:  2007-08-21       Impact factor: 3.996

Review 8.  Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets.

Authors:  Md Sahab Uddin; Abdullah Al Mamun; Md Tanvir Kabir; Ghulam Md Ashraf; May N Bin-Jumah; Mohamed M Abdel-Daim
Journal:  Mol Neurobiol       Date:  2020-09-15       Impact factor: 5.590

9.  Selenium Pretreatment for Mitigation of Ischemia/Reperfusion Injury in Cardiovascular Surgery: Influence on Acute Organ Damage and Inflammatory Response.

Authors:  Holger Steinbrenner; Esra Bilgic; Antonio Pinto; Melanie Engels; Lena Wollschläger; Laura Döhrn; Kristine Kellermann; Udo Boeken; Payam Akhyari; Artur Lichtenberg
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

10.  Different dose-dependent effects of ebselen in sciatic nerve ischemia-reperfusion injury in rats.

Authors:  Filiz Ozyigit; Aysegul Kucuk; Sezer Akcer; Murat Tosun; Fatma Emel Kocak; Cengiz Kocak; Ahmet Kocak; Hasan Metineren; Osman Genc
Journal:  Bosn J Basic Med Sci       Date:  2015-08-26       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.